University of Münster
CRIS@UM
DE | EN

Marc Tim Hennies

No current affiliations available for this person. The person is no longer active at the university.

Publications

Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
Schoefbaenker, M; Günther, T; Lorentzen, EU; Romberg, M-L; Hennies, MT; Neddermeyer, R; Müller, MM; Mellmann, A; Bojarzyn, CR; Lenz, G; Stelljes, M; Hrincius, ER; Vollenberg, R; Ludwig, S; Tepasse, P-R; Kühn, JE (2024)
In: PLoS Pathogens, 20(10), 1-27. doi:10.1371/journal.ppat.1012624
Research article (journal) | Peer reviewed | Published
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.
Schoefbaenker M; Günther T; Lorentzen EU; Romberg ML; Hennies MT; Neddermeyer R; Müller MM; Mellmann A; Bojarzyn CR; Lenz G; Stelljes M; Hrincius ER; Vollenberg R; Ludwig S; Tepasse PR; Kühn JE (2024)
In: PLoS Pathogens, 20(10), e1012624-e1012624. doi:10.1371/journal.ppat.1012624
Research article (journal) | Peer reviewed | Published
COVID-19 rapid molecular point-of-care testing is effective and cost-beneficial for the acute care of trauma patients
Stolberg-Stolberg ,Josef; Jacob, Elena; Kuehn, Joachim; Hennies, Marc; Hafezi, Wali; Freistuehler, Moritz; Koeppe, Jeanette; Friedrich, Alex W.; Katthagen, J. Christoph; Raschke, Michael J. (2023)
In: European Journal of Trauma and Emergency Surgery, 49(1), 487-493. doi:10.1007/s00068-022-02091-x
Research article (journal) | Peer reviewed | Published
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort
Schoefbaenker, M; Neddermeyer, R; Guenther, T; Mueller, MM; Romberg, ML; Classen, N; Hennies, MT; Hrincius, ER; Ludwig, S; Kuehn, JE; Lorentzen, EU (2023)
In: Vaccines, 2023(11), 1-16. doi:10.3390/vaccines11121832
Research article (journal) | Peer reviewed | Published
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
Vollenberg R*, Tepasse P-R*, Kühn JE, Hennies M, Strauss, M Rennebaum F, Schomacher T, Boeckel G, Lorentzen E*, Bokemeyer A*, Nowacki TM* (*equally contributed) (2022)
In: Biomedicines, 10(171). doi:10.3390/biomedicines10010171
Research article (journal) | Peer reviewed | Published
Show all publications